These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812 [TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694 [TBL] [Abstract][Full Text] [Related]
9. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience. Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478 [TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897 [TBL] [Abstract][Full Text] [Related]
11. Refractory coeliac disease. Daum S; Cellier C; Mulder CJ Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in refractory coeliac disease: a review. Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844 [TBL] [Abstract][Full Text] [Related]
13. Cladribine therapy in refractory celiac disease with aberrant T cells. Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946 [TBL] [Abstract][Full Text] [Related]
14. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566 [TBL] [Abstract][Full Text] [Related]
15. Azathioprine and prednisone combination therapy in refractory coeliac disease. Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421 [TBL] [Abstract][Full Text] [Related]
17. Approach to patients with refractory coeliac disease. Nasr I; Nasr I; Campling H; Ciclitira PJ F1000Res; 2016; 5():. PubMed ID: 27803799 [TBL] [Abstract][Full Text] [Related]
18. [Jejunal ulcerations - a diagnostic challenge in a patient with coeliac disease]. Weber M; Schumann M; Felber J; Mireskandari M; Schmidt C; Stallmach A Z Gastroenterol; 2015 Nov; 53(11):1261-6. PubMed ID: 26562400 [TBL] [Abstract][Full Text] [Related]
19. The management of complicated celiac disease. Al-toma A; Verbeek WH; Mulder CJ Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946 [TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of Enteropathy-Associated T Cell Lymphoma. Chander U; Leeman-Neill RJ; Bhagat G Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]